Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES |
|
|
Articles |
|
|
Delivery logistics is critical to COVID-19 vaccine availability.
The opening months of 2021 have revealed the logistical and political intricacies of COVID-19 vaccine manufacturing and deployment.
|
|
|
|
|
| |
|
|
|
ISO 21973: A Leap Forward in Standardizing the Regenerative Medicine Supply Chain.
ISO recently issued crucial guidance for the transportation of cells for therapeutic use. It is imperative for transportation service providers...
|
|
|
| |
|
Time for a Truly Agile, Global Pharmaceutical Supply chain.
Agile supply chains have distinct attributes that help manage vulnerability, disruptions and risk. Recent events demonstrate how valuable an agile process...
|
|
|
|
|
|
Latest News & Press Releases |
|
|
|
|
Russia authorises use of single-dose Covid-19 vaccine Sputnik Light.
Sputnik Light, which is based on the human adenoviral vector platform, is the first component, a recombinant human adenovirus serotype number 26...
|
|
|
| |
|
Novavax Covid-19 vaccine provides cross-protection against B.1.351 variant.
The protein-based vaccine candidate NVX-CoV2373 is made from the genetic sequence of the first SARS-CoV-2 strain. It is adjuvanted with the company's...
|
|
|
|
| | |
|
| |
|
|
|
DCGI approves anti-COVID drug developed by DRDO for emergency use.
The Drugs Controller General of India has approved an anti-COVID oral drug, developed by DRDO, for emergency use as adjunct therapy in moderate...
|
|
|
| |
|
Pfizer and BioNTech Receive First U.S. Authorization for EUA of COVID-19 Vaccine in Adolescents.
Pfizer Inc. and BioNTech SE announced today that the U.S. FDA has expanded the EUA for their COVID-19 vaccine to include individuals 12 to 15 years of age.
|
|
|
|
| | |
|
| |
|
|
|
Vectura and Inspira Pharmaceuticals Sign Agreement to Develop Potential Inhaled Treatment for COVID-19.
Vectura Group company focused on developing therapies for respiratory and infectious diseases, announced an agreement to develop an inhaled...
|
|
|
| |
|
Moderna Announces EUA Listing Granted by the World Health Organization for its COVID-19 Vaccine.
Moderna announced that the WHO has issued Emergency Use Listing for its COVID-19 vaccine to prevent COVID-19 in individuals..
|
|
|
|
| | |
|